Cross-Sectional Study on Factors Associated with Hyperpolypharmacy and Medication Adherence in Older Adults with Multimorbidity and Polypharmacy
Drugs & Aging · 2026
DOI: 10.1007/s40266-025-01263-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Drugs & Aging, 2026. Verfasst von Shanthi Beglinger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Multimorbidity, Polypharmacy, Medication Adherence. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Horizon 2020, Swiss State Secretariat for Education, Research and Innovation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
BACKGROUND: Knowledge of multiple medication use and medication adherence is important to assess treatment effectiveness and prevent worsening of disease, re-hospitalization, and increased healthcare costs. Limited data exist on individuals with hyperpolypharmacy (ten or more concurrent medications) and their adherence. OBJECTIVE: The objective of the study was to identify potential factors associated with hyperpolypharmacy, and medication adherence in participants with hyperpolypharmacy, as well as explore the relationship between hyperpolypharmacy and medication adherence. METHODS: This is a cross-sectional analysis of baseline data from OPERAM, a multicenter study across four large European hospitals. Adults aged ≥ 70 years with multimorbidity and polypharmacy (five or more regular medications) were included. Demographic, clinical, and healthcare utilization data were assessed. Outcomes were hyperpolypharmacy and low/medium medication adherence (i.e., a score < 8 out of a maximum of 8) based on the Morisky Medication Adherence Scale-8 (MMAS-8©). Multivariable logistic regression was used to identify factors associated with hyperpolypharmacy or low/medium adherence. RESULTS: Of 2005 patients with multimorbidity and polypharmacy, 1029 (51%) exhibited hyperpolypharmacy. In multivariable analyses, the following factors were significantly associated with hyperpolypharmacy: increasing number of comorbidities (p for linear trend < 0.001), nursing home residency (odds ratio [OR] 2.20, 95% confidence interval [CI] 1.42-3.41), and visits to specialists/emergency department (OR 1.60, 95% CI 1.16-2.19) or any hospitalizations (OR 1.89, 95% CI 1.42-2.52) compared with visits to primary care physicians only. In the subgroup of 978 hyperpolypharmacy-only adults with available adherence data, 517 (53%) had low/medium medication adherence. In multivariable analyses, the odds of low/medium medication adherence increased with increasing number of comorbidities (p for linear trend 0.005) but decreased with older age (OR 0.69, 95% CI 0.52-0.92 for ≥ 80 versus < 80 years) and receipt of community nurse care (OR 0.59, 95% CI 0.44-0.81). CONCLUSIONS: More than half of older adults with hyperpolypharmacy had suboptimal medication adherence. Our findings suggest that primary care physicians may contribute to reducing hyperpolypharmacy, while introduction of community nurse visits could improve medication adherence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
- Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Medicine (Geriatrics), University College Cork and Cork University Hospital, Cork, Ireland.
- Department of Geriatrics, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
- Louvain Drug Research Institute, Clinical Pharmacy Research Group, Université Catholique de Louvain, Brussels, Belgium.
- Department of Geriatric Medicine and Expertise Center Pharmacotherapy in Old Persons, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
ORCID-Profile: Shanthi Beglinger
Förderung
- Horizon 2020
- Swiss State Secretariat for Education, Research and Innovation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Kollegium für Hausarztmedizin, Switzerland
- University of Bern
Zitieren
APA
Beglinger, S., Bretagne, L., Volery, F., Del Giovane, C., Jungo, K. T., O'Mahony, D., Marien, S., Spinewine, A., Knol, W., Wilting, I., Rodondi, N., & Baumgartner, C. (2026). Cross-Sectional Study on Factors Associated with Hyperpolypharmacy and Medication Adherence in Older Adults with Multimorbidity and Polypharmacy. Drugs & Aging. https://doi.org/10.1007/s40266-025-01263-9
Vancouver
Beglinger S, Bretagne L, Volery F, Del Giovane C, Jungo KT, O'Mahony D, et al. Cross-Sectional Study on Factors Associated with Hyperpolypharmacy and Medication Adherence in Older Adults with Multimorbidity and Polypharmacy. Drugs & Aging. 2026. doi:10.1007/s40266-025-01263-9
BibTeX
@article{Beglinger2026,
author = {Beglinger, Shanthi and Bretagne, Lisa and Volery, François and Del Giovane, Cinzia and Jungo, Katharina T and O'Mahony, Denis and Marien, Sophie and Spinewine, Anne and Knol, Wilma and Wilting, Ingeborg and Rodondi, Nicolas and Baumgartner, Christine},
title = {Cross-Sectional Study on Factors Associated with Hyperpolypharmacy and Medication Adherence in Older Adults with Multimorbidity and Polypharmacy},
journal = {Drugs & Aging},
year = {2026},
doi = {10.1007/s40266-025-01263-9}
}
EUVIMED